STOCK TITAN

[DEFA14A] BioLife Solutions Inc. Additional Proxy Soliciting Materials

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
DEFA14A
Rhea-AI Filing Summary
-
-
-
-
-
Positive
  • None.
Negative
  • None.
-
-
-
-
-
0000834365DEFA14Afalse00008343652023-01-012023-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(RULE 14a-101)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant
Filed by a Party other than the Registrant o

Check the appropriate box:

oPreliminary Proxy Statement
oConfidential, For Use of the Commission Only (As Permitted by Rule 14a-6(e)(2))
oDefinitive Proxy Statement
Definitive Additional Materials
oSoliciting Material under Rule 14a-12
BIOLIFE SOLUTIONS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
xNo fee required.
oFee paid previously with preliminary materials
oFee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11





bioli20230601_def14aimg001.jpg

DEFA 14A - First Page.jpg



DEFA 14A - Second Page.jpg

Biolife Solutions Inc

NASDAQ:BLFS

BLFS Rankings

BLFS Latest News

BLFS Latest SEC Filings

BLFS Stock Data

1.09B
46.22M
1.85%
101.8%
7.24%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
BOTHELL